Squarepoint’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-42,977
| Closed | -$2.38M | – | 4833 |
|
|
2026
Q1 | $2.38M | Sell |
42,977
-55,593
| -56% | -$2.65M | ﹤0.01% | 2051 |
|
|
2025
Q4 | $3.68M | Sell |
98,570
-5,302
| -5% | -$215K | ﹤0.01% | 1654 |
|
|
2025
Q3 | $4.2M | Buy |
103,872
+72,028
| +226% | +$2.38M | ﹤0.01% | 1569 |
|
|
2025
Q2 | $813K | Buy |
+31,844
| New | +$694K | ﹤0.01% | 2846 |
|
|
2024
Q3 | – | Sell |
-13,582
| Closed | -$228K | – | 4546 |
|
|
2024
Q2 | $228K | Sell |
13,582
-21,553
| -61% | -$346K | ﹤0.01% | 3583 |
|
|
2024
Q1 | $454K | Sell |
35,135
-26,285
| -43% | -$315K | ﹤0.01% | 3114 |
|
|
2023
Q4 | $711K | Buy |
+61,420
| New | +$693K | ﹤0.01% | 2757 |
|
|
2022
Q1 | – | Sell |
-11,795
| Closed | -$241K | – | 3340 |
|
|
2021
Q4 | $241K | Buy |
+11,795
| New | +$252K | ﹤0.01% | 2583 |
|
|
2021
Q1 | – | Sell |
-31,254
| Closed | -$607K | – | 3493 |
|
|
2020
Q4 | $607K | Sell |
31,254
-12,761
| -29% | -$235K | ﹤0.01% | 1663 |
|
|
2020
Q3 | $766K | Buy |
+44,015
| New | +$939K | 0.01% | 1141 |
|
|
2020
Q2 | – | Sell |
-14,237
| Closed | -$344K | – | 2444 |
|
|
2020
Q1 | $344K | Sell |
14,237
-34,443
| -71% | -$842K | 0.01% | 1235 |
|
|
2019
Q4 | $1.21M | Buy |
48,680
+20,124
| +70% | +$467K | 0.01% | 1224 |
|
|
2019
Q3 | $609K | Sell |
28,556
-8,521
| -23% | -$233K | 0.01% | 1514 |
|
|
2019
Q2 | $1.18M | Buy |
37,077
+10,173
| +38% | +$319K | 0.01% | 1164 |
|
|
2019
Q1 | $888K | Sell |
26,904
-564
| -2% | -$17.6K | 0.01% | 1166 |
|
|
2018
Q4 | $883K | Buy |
27,468
+11,493
| +72% | +$434K | 0.01% | 976 |
|
|
2018
Q3 | $685K | Buy |
+15,975
| New | +$755K | 0.01% | 1162 |
|
|
2018
Q2 | – | Sell |
-18,409
| Closed | -$731K | – | 1970 |
|
|
2018
Q1 | $731K | Buy |
18,409
+2,161
| +13% | +$80K | 0.01% | 934 |
|
|
2017
Q4 | $544K | Sell |
16,248
-2,398
| -13% | -$85.1K | 0.01% | 1158 |
|
|
2017
Q3 | $691K | Buy |
18,646
+3,928
| +27% | +$148K | 0.01% | 859 |
|
|
2017
Q2 | $545K | Buy |
+14,718
| New | +$480K | 0.01% | 920 |
|
|
2016
Q2 | – | Sell |
-8,510
| Closed | -$230K | – | 1287 |
|
|
2016
Q1 | $230K | Buy |
+8,510
| New | +$244K | 0.02% | 942 |
|
Other funds holding PAHC
Squarepoint's PAHC Position: Q2 2026 in Review
Squarepoint sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 42,977 shares — an estimated $2.38M sold.
Squarepoint first reported a position in PAHC in Q1 2016 and held it in 22 quarters. The position peaked at $4.2M in Q3 2025. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Squarepoint reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
- Squarepoint sold 42,977 Phibro Animal Health shares in Q2 2026, an estimated $2.38M.
- Squarepoint first reported a position in Phibro Animal Health in Q1 2016 and held it in 22 quarters.
- Squarepoint's Phibro Animal Health position peaked at $4.2M in Q3 2025.
- 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.